Medifast, Inc., the parent company of Trilivy, has established the Medifast Metabolic Health Institute, bringing rigorous research and evidence-based education to its approach to metabolic health. Through the institute, Medifast will gather its clinical research, scientific expertise and educational resources under a single body to support its belief that everyone deserves access to the science, education, tools and support necessary to achieve optimal metabolic health.

Medifast announced its financial results for the second quarter of 2026. Revenue during the quarter was $76.4 million, a 27.6% decrease from Q2 2025, with a net loss of $3.1 million, or $0.28 per diluted share.

Medifast, the parent company of OPTAVIA, debuted Trilivy, a comprehensive metabolic health system designed to support healthy lifestyle change. Included in the launch is the Trilivy Reset Fueling line, an array of new meal replacement options formulated with proprietary ingredients to support key metabolic pathways, normal fat metabolism and healthy insulin function. Trilivy is structured […]